Macrogenics Overview
Macrogenics Target Price
Analysts' 12-month price predictions for MGNX.
Share Price
$1.46
Average Target Price
$2.50
71.2% upside
71.2% upside2 analysts in the last 4 months
High: $3 | Low: $2
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-05-14 | BarclaysPeter Lawson | $3 | 105.5% upside |  |
| 2025-03-25 | H.C. Wainwright | $2 | 37% upside | |
| 2024-08-07 | Stifel NicolausStephen Willey | $6 | 311% upside | |
| 2024-07-31 | JMP SecuritiesSilvan Tuerkcan | $8 | 447.9% upside | |
| 2024-07-31 | B.Riley FinancialMayank Mamtani | $5 | 242.5% upside | |
| 2024-07-29 | BarclaysPeter Lawson | $9 | 516.4% upside | |
| 2024-05-23 | BTIGKaveri Pohlman | $9 | 516.4% upside | |
| 2024-05-13 | H.C. WainwrightDebjit Chattopadhyay | $4 | 174% upside | |
| 2024-05-10 | BarclaysPeter Lawson | $14 | 858.9% upside | |
| 2024-05-10 | BMO CapitalEtzer Darout | $8 | 447.9% upside | |
| 2024-04-04 | Stifel NicolausStephen Willey | $29 | 1886.3% upside | |
| 2022-11-22 | GuggenheimCharles Zhu | $12 | 721.9% upside | |
| 2022-07-11 | BTIGKaveri Pohlman | $6 | 311% upside | |
| 2021-06-16 | WedbushDavid Nierengarten | $32 | 2091.8% upside | |